ZYME Releasing Clinical Trial Data January 15

Zymeworks is releasing a new drug, ZW25, to treat HER2-expressing Gastroesophageal Adenocarcinoma. The phase one trials for this drug done, and the data for the trials will be released on January 15, 2021. For optimal gains, buy a week in advance and sell the day of the data release. Again, the data will be released 11:30-12:15 EST on January 15, 2021. Like and follow for more picks like this.
Fundamental Analysisinvestorcentral

他のメディア:

免責事項